SEC Form 4 · accession 0001179110-17-015160
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Miles D White
Officer — Chairman and CEO · Director
Period of report
Dec 6, 2017
Accepted (ET)
Dec 8, 2017 · 5:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Dec 6, 2017 | S | 103 | $54.915 | D | 3,158,454 | D | |
| Common shares without par value | Dec 6, 2017 | S | 3,300 | $54.92 | D | 3,155,154 | D | |
| Common shares without par value | Dec 6, 2017 | S | 392 | $54.925 | D | 3,154,762 | D | |
| Common shares without par value | Dec 6, 2017 | S | 1,600 | $54.93 | D | 3,153,162 | D | |
| Common shares without par value | Dec 6, 2017 | S | 1,200 | $54.94 | D | 3,151,962 | D | |
| Common shares without par value | Dec 6, 2017 | S | 200 | $54.945 | D | 3,151,762 | D | |
| Common shares without par value | Dec 6, 2017 | S | 428 | $54.95 | D | 3,151,334 | D | |
| Common shares without par value | Dec 6, 2017 | S | 3 | $54.955 | D | 3,151,331 | D | |
| Common shares without par value | Dec 6, 2017 | S | 400 | $54.96 | D | 3,150,931 | D | |
| Common shares without par value | Dec 6, 2017 | S | 100 | $54.965 | D | 3,150,831 | D | |
| Common shares without par value | Dec 6, 2017 | S | 1,199 | $54.97 | D | 3,149,632 | D | |
| Common shares without par value | Dec 6, 2017 | S | 200 | $54.975 | D | 3,149,432 | D | |
| Common shares without par value | Dec 6, 2017 | S | 615 | $54.98 | D | 3,148,817 | D | |
| Common shares without par value | Dec 6, 2017 | S | 600 | $54.99 | D | 3,148,217 | D | |
| Common shares without par value | Dec 6, 2017 | S | 100 | $55.00 | D | 3,148,117 | D | |
| Common shares without par valueF1 | Dec 6, 2017 | S | 204 | $55.02 | D | 3,148,022 | D | |
| Common shares without par valueF2 | holding | — | — | — | 31,675 | I | Profit Sharing Trust | |
| Common shares without par valueF3 | holding | — | — | — | 9,498 | I | By Son | |
| Common shares without par valueF3 | holding | — | — | — | 9,512 | I | By Son |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes shares acquired by the Judith S. White Living Trust under the Abbott Laboratories Dividend Reinvestment and Share Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11.
- F2Balance in the Abbott Laboratories Stock Retirement Trust as of December 6, 2017.
- F3The reporting person disclaims beneficial ownership of all securities held by his son.
Remarks
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).Form 5 of 5.